BioSpace News Archive

Drug Development

Provention Bio’s Crohn’s Disease Drug Flunks Mid-Stage Trial

The drug showed what the company is calling a “substantial improvement in this symptom-driven score” at the 12-week point, but it did not differentiate from placebo.

October 23, 2019
·
3 min read
·
Mark Terry
How to Show Your Boss You’re Ready for a Promotion

You’ve had your job for a while now. You’ve gotten multiple great reviews. You’ve consistently taken on additional projects and excelled at them. But you have yet to receive a promotion and you’re left wondering “Why?”.

October 23, 2019
·
2 min read
·
Laura Brothers
Pharm Country

BrainStorm Cell Therapeutics Presentations at Neuromuscular Drug Development Summit

BrainStorm Cell Therapeutics Inc. will be participating and presenting scientific data at the upcoming Neuromuscular Drug Development Summit, from October 23-25th, in Boston MA. The Summit is dedicated to solving the challenges in developing second generation neuromuscular therapeutics..

October 23, 2019
·
5 min read
Drug Development

Sensorion Announces a Poster Presentation of New SENS-401 Preclinical Data at SFN 2019 in Chicago

A poster presentation on the absence of impact due to acoustic trauma on the SENS-401 inner ear exposure in preclinical studies

October 23, 2019
·
5 min read
Job Trends

Elekta Wins the Technology Services Industry Association STAR award

Award is one of the highest honors in the category of field service, recognizing commitment to outstanding innovation, leadership and excellence

October 23, 2019
·
3 min read
Business

Invitation - Presentation of Sobi’s Q3 2019 Results

On 31 October, at 08:00 CET, Swedish Orphan Biovitrum AB will publish its report for the third quarter 2019.

October 23, 2019
·
1 min read
Policy

Dr. Reddy’s Confirms Its Voluntary Nationwide Recall of All Ranitidine Products in the U.S. Market

Dr. Reddy’s Laboratories Ltd. confirms it had initiated a voluntary nationwide recall on October 1, 2019, of all of its ranitidine medications sold in US due to confirmed contamination with N-Nitrosodimethylamine above levels established by the FDA.

October 23, 2019
·
7 min read
Biotech Beach

Wexford Health Sources, Inc. Selects NantHealth’s Eviti® Connect to Bring Evidence-Based Standards and Value-Based Oncology Care to Patients

NantHealth, Inc., a next-generation, evidence-based, personalized healthcare company, announced its new customer, Wexford Health Sources, Inc.

October 23, 2019
·
3 min read
Deals

MediciNova Receives Notice of Allowance for New Patent Covering MN-001 for the Treatment of NAFLD and NASH in Japan

MediciNova, Inc. announced that it has received a Notice of Allowance from the Japan Patent Office for a pending patent application which covers MN-001 for the treatment of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis

October 23, 2019
·
5 min read
Business

Enrique Conterno, Senior Vice President and President of Lilly Diabetes and Lilly USA, to Retire at End of Year; Mike Mason to Succeed Conterno

Eli Lilly and Company announced that Enrique Conterno, senior vice president of Lilly and president of Lilly Diabetes and Lilly USA, will retire at the end of the year after 27 years of service with the company.

October 23, 2019
·
3 min read